Evidence map›Paper›PMID 18639552›Full record

ArticleGastroenterology2008

Genetic variants in major histocompatibility complex-linked genes associate with pediatric liver transplant rejection.

Rakesh Sindhi, Brandon W Higgs, Daniel E Weeks, Chethan Ashokkumar, Ronald Jaffe, Cecilia Kim, Patrick Wilson, Nydia Chien, Joseph Glessner, Anjan Talukdar and 7 more

Open access · greenAbstract read
In one paragraph

Article in Gastroenterology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  6. Article
  7. Proteoforms in Peripheral Blood Mononuclear Cells as Novel Rejection Biomarkers in Liver Transplant Recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2017
    Article
  8. Transplant genetics and genomics.Nature reviews. Genetics · 2017
    Review
  9. Article
  10. Enhanced B Cell Alloantigen Presentation and Its Epigenetic Dysregulation in Liver Transplant Rejection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2016
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Rakesh SindhiHillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA. Rakesh.Sindhi@chp.edu
Brandon W Higgs
Daniel E Weeks
Chethan Ashokkumar
Ronald Jaffe
Cecilia Kim
Patrick Wilson
Nydia Chien
Joseph Glessner
Anjan Talukdar
George Mazariegos
M Michael Barmada
Edward Frackleton
Nancy Petro
Andrew Eckert
Hakon Hakonarson
Robert Ferrell
Children's Hospital of Pittsburgh · USChildren's Hospital of Philadelphia · USUniversity of Pittsburgh · US

Funding

Predictors for drug selection and minimization in pediatric liver transplantationR01AI073895 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SINDHI, RAKESH K. · 2006 to 2009
$1.5M
NIAID NIH HHS 5R01AI073895-01NIAID NIH HHS R01 AI073895
6 · The paper itself

Abstract

BACKGROUND &

aimsLimited access to large samples precludes genome-wide association studies of rare but complex traits. To localize candidate genes with family-based genome-wide association, a novel exploratory analysis was first tested on 1774 major histocompatibility complex single nucleotide polymorphisms (SNPs) in 240 DNA samples from 80 children with primary liver transplantation and their biologic parents.

methodsInitially, 57 SNPs with large differences (P < .05) in minor allele frequencies were selected when parents of children with early rejection (rejectors) were compared with parents of nonrejectors.

resultsIn hypothesis testing of selected SNPs, the gamete competition statistic identified the minor allele G of the SNP rs9296068, near HLA-DOA, as being significantly different (P = .018) between outcome groups in parent-to-child transmission. Subsequent simple association testing confirmed over- and undertransmission of rs9296068 based on the most significant differences between outcome groups, of 1774 SNPs tested (P = .002), and allele (G) frequencies that were greater among rejectors (51.4% vs 36.8%, respectively, P = .015) and lower among nonrejectors (26.8% vs 36.8%, respectively, P = .074) compared with 400 normal control Caucasian children. In early functional validation, rejectors demonstrated significant repression of the first HLA-DOA exon closest to rs9296068. Also, intragraft B lymphocytes, whose antigen-presenting function is selectively inhibited by HLA-DOA were 3-fold more numerous during rejection among rejectors with the risk allele, than those without.

conclusionsThe minor allele of the SNP rs9296068 is significantly associated with liver transplantation rejection and with enhanced B-lymphocyte participation in rejection, likely because of a dysfunctional HLA-DOA gene product.

Indexed as

Liver TransplantationPolymorphism, Single NucleotideB-LymphocytesCell CountChildChild, PreschoolFemaleGene FrequencyGenetic VariationGenotypeGraft RejectionHLA-D AntigensHumansMaleParentsHLA-D AntigensHLA-DO antigens

Identifiers

PMID18639552
PMCPMC2956436
OpenAlexW2013824452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.